Lahesmaa, Riitta

Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells

Koh, K. P., Yabuuchi, A., Rao, S., Huang, Y., Cunniff, K., Nardone, J., Laiho, A., Tahiliani, M., Sommer, C. A., Mostoslavsky, G., et al. (2011) · Cell Stem Cell

Pluripotent Stem Cells ResearchEpigenetics and DNA Methylation

Cited by 776

Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes

Orešič, M., Simell, S., Sysi-Aho, M., Näntö-Salonen, K., Seppänen-Laakso, T., Parikka, V., Katajamaa, M., Hekkala, A., Mattila, I., Keskinen, P., et al. (2008) · The Journal of Experimental Medicine

Diabetes and associated disordersMetabolomics and Mass Spectrometry Studies

Cited by 449

Genomic views of STAT function in CD4+ T helper cell differentiation

O'Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A., & Kanno, Y. (2011) · Nature Reviews Immunology

Cytokine Signaling Pathways and InteractionsT-cell and B-cell Immunology

Cited by 295

Timing of infant feeding in relation to childhood asthma and allergic diseases

Nwaru, B. I., Takkinen, H.-M., Niemelä, O., Kaila, M., Erkkola, M., Ahonen, S., Haapala, A.-M., Kenward, M. G., Pekkanen, J., Lahesmaa, R., et al. (2013) · Journal of Allergy and Clinical Immunology

Asthma and respiratory diseasesFood Allergy and Anaphylaxis Research

Cited by 151

Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation

Mathiasen, D. P., Egebjerg, C., Andersen, S. H., Rafn, B., Puustinen, P., Khanna, A., Daugaard, M., Valo, E., Tuomela, S., Bøttzauw, T., et al. (2012) · Oncogene

Protein Kinase Regulation and GTPase SignalingMelanoma and MAPK Pathways

Cited by 44

CIP2A promotes T-cell activation and immune response to Listeria monocytogenes infection

Côme, C., Cvrljevic, A., Khan, M. M., Treise, I., Adler, T., Aguilar-Pimentel, J. A., Au-Yeung, B., Sittig, E., Laajala, T. D., Chen, Y., et al. (2016) · PLoS ONE

T-cell and B-cell ImmunologySignaling Pathways in Disease

Cited by 20

Minimum effective low dose of antithymocyte globulin in people aged 5–25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial

Mathieu, C., Wych, J., Hendriks, A. E. J., Van Ryckeghem, L., Tree, T., Chmura, P., Möller, C., Casteels, K., Danne, T., Reschke, F., et al. (2025) · The Lancet

Diabetes and associated disordersDiabetes Management and Research

Cited by 17